A nurse is caring for a client whose partner recently died. The nurse sits with the client to provide comfort.

Which of the following ethical principles is the nurse demonstrating?

Beneficence is the ethical principle of doing good for the patient and promoting their well-being.
The nurse is demonstrating beneficence by sitting with the client to provide comfort and support during a difficult time.
Choice B is wrong because fidelity is the ethical principle of keeping promises to the patient and being loyal and faithful.
The nurse is not making or keeping any promises to the client in this scenario.
Choice C is wrong because autonomy is the ethical principle of respecting the patient’s right to make their own decisions and choices.
The nurse is not interfering with the client’s autonomy in this scenario.
Choice D is wrong because veracity is the ethical principle of telling the truth to the patient and being honest and trustworthy.
The nurse is not lying or withholding information from the client in this scenario.

Alteplase is a drug that dissolves blood clots by converting plasminogen to plasmin. It can be used for acute ischemic stroke, but it has some contraindications that depend on the indication and the type of administration of the drug. Some common contraindications for alteplase are hypersensitivity, active internal bleeding, a history of intracranial hemorrhage, bleeding disorders, and high blood pressure. Other contraindications may vary depending on the specific condition and the time window of treatment. Alteplase can cause serious or fatal bleeding as a side effect.

Choice A is wrong because a family history of malignant hypertension is not an absolute contraindication for alteplase, although uncontrolled hypertension (>185 mmHg SBP or >110 mmHg DBP) is.

Choice C is wrong because chronic obstructive pulmonary disease is not a contraindication for alteplase, although it may increase the risk of pulmonary hemorrhage.

Choice D is wrong because acute renal failure 6 months ago is not a contraindication for alteplase, although the current use of direct thrombin inhibitors or direct factor Xa inhibitors is.
Normal ranges for blood pressure are <120/80 mmHg for normal, 120-129/<80 mmHg for elevated, 130-139/80-89 mmHg for stage 1 hypertension, and ≥140/≥90 mmHg for stage 2 hypertension.
Normal ranges for platelet count are 150,000 to 450,000 platelets per microliter of blood.
Normal ranges for INR are 0.8 to 1.2 for people who are not taking blood thinners and 2 to 3 for people who are taking warfarin.
Normal ranges for aPTT are 25 to 35 seconds for people who are not taking blood thinners and 46 to 70 seconds for people who are taking heparin.